Welcome to our dedicated page for MeiraGTx Holdings plc SEC filings (Ticker: MGTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MeiraGTx Holdings plc filings document a clinical-stage genetic medicines company with ordinary shares listed on Nasdaq under MGTX. The company’s 8-K reports cover material definitive agreements, collaboration and license arrangements, asset purchases for genetic-medicine programs, Regulation FD clinical disclosures, operating and financial results, and amendments to note and warrant financing arrangements.
Its proxy materials describe shareholder voting matters, board governance, executive compensation, equity awards, and related corporate-governance disclosures. The filing record also documents capital structure, subsidiary guarantor arrangements, risk-oriented clinical and regulatory disclosures, and program-specific matters involving AAV-hAQP1, AAV-AIPL1, RPGR-related X-linked retinitis pigmentosa assets, and riboswitch technology.
MeiraGTx Holdings plc director Debra Yu received a grant of 60,000 restricted share units (RSUs). These RSUs were awarded as a stock-based compensation grant and each unit will convert into one ordinary share when settled.
The RSUs are scheduled to vest in a single installment on the earlier of June 11, 2027, or the day immediately before MeiraGTx’s 2027 annual shareholder meeting. The reporting person has elected that the RSUs become settleable when she ceases to be a director, so actual share delivery will occur at that time. Following this grant, she holds 60,000 RSUs directly.
SHENK THOMAS E reported acquisition or exercise transactions in this Form 4 filing.
MeiraGTx Holdings plc director Thomas E. Shenk received a grant of 69,662 restricted share units. Each unit represents the right to receive one ordinary share upon settlement. The filing shows he now holds 69,662 restricted share units directly after this award.
The units will vest in a single annual installment on the earlier of June 11, 2027 or the day immediately prior to MeiraGTx’s 2027 annual meeting of shareholders. The reporting person elected to have the restricted share units become settleable when he ceases to be a director.
MeiraGTx Holdings plc director Nicole Seligman received a grant of 60,000 restricted share units (RSUs). The award was made on June 11, 2026 and is a form of equity compensation, not an open‑market share purchase or sale.
Each RSU converts into one ordinary share upon settlement. The RSUs vest in a single installment on the earlier of June 11, 2027 or the day immediately prior to MeiraGTx’s 2027 annual shareholder meeting. Seligman elected to have the RSUs become settleable when she ceases to be a director, and following this grant she holds 60,000 RSUs.
MeiraGTx Holdings plc director Neil Mendoza received a grant of 66,641 restricted share units (RSUs) on June 11, 2026. Each RSU converts into one ordinary share upon settlement. The RSUs vest in a single installment on the earlier of June 11, 2027 or the day immediately prior to MeiraGTx’s 2027 annual shareholder meeting. Mendoza elected to have the RSUs become settleable when he ceases to be a director, and his reported RSU holdings after this grant total 66,641 units.
MeiraGTx Holdings plc director Ellen Hukkelhoven received a grant of 60,000 Restricted Share Units (RSUs). These RSUs were awarded as a compensation-related grant with no cash price per unit and are reported as a derivative security linked to the company’s ordinary shares.
Each RSU converts into one ordinary share upon settlement. According to the terms, the RSUs will vest in a single installment on the earlier of June 11, 2027 or the day immediately before MeiraGTx’s 2027 annual shareholder meeting. The reporting person elected to have the RSUs become settleable when she ceases to be a director.
Harris Keith R. reported acquisition or exercise transactions in this Form 4 filing.
MeiraGTx Holdings plc director Harris Keith R. received a grant of 106,441 restricted share units as equity compensation. Each unit represents the right to receive one ordinary share upon settlement. These restricted share units vest in a single installment on the earlier of June 11, 2027 or the day immediately before the company’s 2027 annual shareholder meeting. Following this grant, Harris holds 106,441 restricted share units directly.
MeiraGTx Holdings plc reported results of its annual general meeting held on June 11, 2026. Shareholders representing 75,326,022 ordinary shares, about 81.4% of shares outstanding as of the April 21, 2026 record date, were present or represented by proxy.
Three Class II directors — Ellen Hukkelhoven, Ph.D., Nicole Seligman and Debra Yu, M.D. — were elected to serve until the 2029 annual meeting and until their successors are elected and qualified. Shareholders also approved the ratification of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026, with 73,933,288 votes for, 1,029,075 against, and 363,659 abstaining.
PERCEPTIVE ADVISORS LLC reported acquisition or exercise transactions in this Form 4 filing.
MeiraGTx Holdings plc reported a new equity award to a Perceptive Advisors–related entity tied to board service. Perceptive-affiliated holders received 60,000 restricted share units, each convertible into one ordinary share upon settlement. The units vest in a single installment on the earlier of June 11, 2027 or the day before the company’s 2027 annual shareholder meeting, and become settleable when director Ellen Hukkelhoven leaves the board. The filing notes Perceptive Advisors, its master fund, and Joseph Edelman may be deemed to have only an indirect pecuniary interest and each disclaims beneficial ownership beyond that indirect interest. This is a compensation-related equity grant rather than an open-market purchase or sale.
MeiraGTx Holdings plc director Harris Keith R. exercised equity awards to acquire additional stock. He converted 75,000 restricted share units into 75,000 ordinary shares through an exercise or conversion of a derivative security, with no reported purchase price.
Following this transaction, his direct holdings in ordinary shares increased to 200,000 shares. The related derivative position in these 75,000 restricted share units is now shown as fully converted, reflecting a routine compensation-related equity settlement rather than an open-market trade.
MeiraGTx Holdings plc executive Richard Giroux reported a bona fide gift of company shares. The CFO & COO gifted 7,000 Ordinary Shares at a price of $0.0000 per share and now holds 964,530 Ordinary Shares directly. He also reports indirect ownership of 85,000 Ordinary Shares through Aigle Healthcare Partners III LLC and 5,152 Ordinary Shares held by his spouse.